Veterinary Medicine Information website

Arvilap - Injektionssuspension für Kaninchen

Authorised
  • Rabbit haemorrhagic disease virus, type 1, strain LO1, Inactivated
Download as PDF

Product identification

Medicine name:
Arvilap - Injektionssuspension für Kaninchen
Active substance:
  • Rabbit haemorrhagic disease virus, type 1, strain LO1, Inactivated
Target species:
  • Rabbit
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabbit haemorrhagic disease virus, type 1, strain LO1, Inactivated
    80.00
    haemagglutination inhibiting unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI08AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - New active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Ovejero S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Ovejero S.A.U.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-20079
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 22/03/2018
Updated on: 2/05/2024
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 22/03/2018
Updated on: 2/05/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 22/03/2018
Updated on: 2/05/2024
Download